标题
Novel Platforms for the Development of a Universal Influenza Vaccine
作者
关键词
-
出版物
Frontiers in Immunology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-03-23
DOI
10.3389/fimmu.2018.00600
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder
- (2018) Edward A. Belongia et al. VACCINE
- Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture
- (2018) Daniela S. Rajão et al. Frontiers in Microbiology
- Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design
- (2017) Timothy Pepini et al. JOURNAL OF IMMUNOLOGY
- Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination
- (2017) Kristin G. I. Mohn et al. JOURNAL OF INFECTIOUS DISEASES
- Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model
- (2017) Megan E. Ermler et al. JOURNAL OF VIROLOGY
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- The Advisory Committee on Immunization Practices’ controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection
- (2017) Parker A. Small et al. VACCINE
- An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice
- (2017) Eun Kim et al. Viruses-Basel
- An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial
- (2017) Adam D. DeZure et al. npj Vaccines
- A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies
- (2017) Raffael Nachbagauer et al. npj Vaccines
- Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers
- (2016) Jeremy J. Lim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults
- (2016) Stéphane Pillet et al. CLINICAL IMMUNOLOGY
- Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines
- (2016) Christopher S Ambrose et al. Eurosurveillance
- Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins
- (2016) Chi-Jene Chen et al. JOURNAL OF VIROLOGY
- Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
- (2016) Diletta Magini et al. PLoS One
- Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks
- (2016) Andrew M. Wollacott et al. EBioMedicine
- A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice
- (2016) Raffael Nachbagauer et al. npj Vaccines
- Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine
- (2016) Nuriban Valero-Pacheco et al. PLoS One
- Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
- (2016) Theone C. Kon et al. PLoS One
- Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin
- (2015) Michela Brazzoli et al. JOURNAL OF VIROLOGY
- Advances in the development of influenza virus vaccines
- (2015) Florian Krammer et al. NATURE REVIEWS DRUG DISCOVERY
- An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
- (2015) Louis M. Schwartzman et al. mBio
- Development of high-yield influenza A virus vaccine viruses
- (2015) Jihui Ping et al. Nature Communications
- Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans
- (2015) Marie Borggren et al. Human Vaccines & Immunotherapeutics
- The contrasting phylodynamics of human influenza B viruses
- (2015) Dhanasekaran Vijaykrishna et al. eLife
- B Cells and Functional Antibody Responses to Combat Influenza
- (2015) Giuseppe Lofano et al. Frontiers in Immunology
- Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
- (2014) Raquel P Deering et al. Expert Opinion on Drug Delivery
- Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
- (2014) Alicia Rodriguez-Gascon et al. International Journal of Nanomedicine
- Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza
- (2014) Eleanor L. Ramos et al. JOURNAL OF INFECTIOUS DISEASES
- Mucosal Immunization with a Candidate Universal Influenza Vaccine Reduces Virus Transmission in a Mouse Model
- (2014) G. E. Price et al. JOURNAL OF VIROLOGY
- Broad Protection against Avian Influenza Virus by Using a Modified Vaccinia Ankara Virus Expressing a Mosaic Hemagglutinin Gene
- (2014) A. Kamlangdee et al. JOURNAL OF VIROLOGY
- Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets
- (2014) F. Krammer et al. JOURNAL OF VIROLOGY
- Single-Domain Antibodies Targeting Neuraminidase Protect against an H5N1 Influenza Virus Challenge
- (2014) F. M. Cardoso et al. JOURNAL OF VIROLOGY
- Rapid development of broadly influenza neutralizing antibodies through redundant mutations
- (2014) Leontios Pappas et al. NATURE
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
- (2014) Danuta M. Skowronski et al. PLoS One
- Effects of Vaccination and the New Neuraminidase Inhibitor, Laninamivir, on Influenza Infection
- (2014) Takuro Mizuno et al. PLoS One
- Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity
- (2014) Min-Chul Kim et al. VACCINE
- Priming by a novel universal influenza vaccine (Multimeric-001)—A gateway for improving immune response in the elderly population
- (2014) Jacob Atsmon et al. VACCINE
- Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers
- (2014) Jenny G.H. Low et al. VACCINE
- Options and Obstacles for Designing a Universal Influenza Vaccine
- (2014) Yo Jang et al. Viruses-Basel
- In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen
- (2014) Teddy Wohlbold et al. Viruses-Basel
- Influenza Virus Drug Resistance: A Time-Sampled Population Genetics Perspective
- (2014) Matthieu Foll et al. PLoS Genetics
- Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge
- (2013) Xiao Gao et al. ANTIVIRAL RESEARCH
- Traditional and New Influenza Vaccines
- (2013) S.-S. Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Development of universal influenza vaccines based on influenza virus M and NP genes
- (2013) M. Zheng et al. INFECTION
- Protective CD8 T Cell-Mediated Immunity against Influenza A Virus Infection following Influenza Virus-like Particle Vaccination
- (2013) E. A. Hemann et al. JOURNAL OF IMMUNOLOGY
- The highly conserved HA2 protein of the influenza a virus induces a cross protective immune response
- (2013) Jong-Soo Lee et al. JOURNAL OF VIROLOGICAL METHODS
- H3N2 Influenza Virus Infection Induces Broadly Reactive Hemagglutinin Stalk Antibodies in Humans and Mice
- (2013) I. Margine et al. JOURNAL OF VIROLOGY
- Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
- (2013) F. Krammer et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
- (2013) Marc Gurwith et al. LANCET INFECTIOUS DISEASES
- Unknown
- (2013) Teresa Lambe MOLECULAR MEDICINE
- Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- Cellular immune correlates of protection against symptomatic pandemic influenza
- (2013) Saranya Sridhar et al. NATURE MEDICINE
- In Vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle
- (2013) Satoshi Uchida et al. PLoS One
- Bacterially Produced Recombinant Influenza Vaccines Based on Virus-Like Particles
- (2013) Andrea Jegerlehner et al. PLoS One
- Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics
- (2013) P. R. Dormitzer et al. Science Translational Medicine
- Glycosylations in the Globular Head of the Hemagglutinin Protein Modulate the Virulence and Antigenic Properties of the H1N1 Influenza Viruses
- (2013) R. A. Medina et al. Science Translational Medicine
- RNA: The new revolution in nucleic acid vaccines
- (2013) Andrew J. Geall et al. SEMINARS IN IMMUNOLOGY
- Virus-like particle-based human vaccines: quality assessment based on structural and functional properties
- (2013) Qinjian Zhao et al. TRENDS IN BIOTECHNOLOGY
- Natural history of highly pathogenic avian influenza H5N1
- (2013) Stephanie Sonnberg et al. VIRUS RESEARCH
- Bringing influenza vaccines into the 21st century
- (2013) Ethan C Settembre et al. Human Vaccines & Immunotherapeutics
- Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity
- (2013) Brian J. Laidlaw et al. PLoS Pathogens
- New World Bats Harbor Diverse Influenza A Viruses
- (2013) Suxiang Tong et al. PLoS Pathogens
- Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice
- (2013) Armin Hekele et al. Emerging Microbes & Infections
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
- (2012) S. Van Lint et al. CANCER RESEARCH
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
- (2012) Patrick J. Lillie et al. CLINICAL INFECTIOUS DISEASES
- Technologies for enhanced efficacy of DNA vaccines
- (2012) Fadi Saade et al. Expert Review of Vaccines
- Virus-like particles as universal influenza vaccines
- (2012) Sang-Moo Kang et al. Expert Review of Vaccines
- A Computationally Optimized Hemagglutinin Virus-Like Particle Vaccine Elicits Broadly Reactive Antibodies that Protect Nonhuman Primates from H5N1 Infection
- (2012) Brendan M. Giles et al. JOURNAL OF INFECTIOUS DISEASES
- Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in Adults
- (2012) Maria Ines Barría et al. JOURNAL OF INFECTIOUS DISEASES
- ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases
- (2012) A. Baz Morelli et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Recombinant Parainfluenza Virus 5 Vaccine Encoding the Influenza Virus Hemagglutinin Protects against H5N1 Highly Pathogenic Avian Influenza Virus Infection following Intranasal or Intramuscular Vaccination of BALB/c Mice
- (2012) A. J. Mooney et al. JOURNAL OF VIROLOGY
- Multifunctional CD4 Cells Expressing Gamma Interferon and Perforin Mediate Protection against Lethal Influenza Virus Infection
- (2012) D. M. Brown et al. JOURNAL OF VIROLOGY
- Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus
- (2012) Min-Chul Kim et al. MOLECULAR THERAPY
- Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
- (2012) Charlotte Pollard et al. MOLECULAR THERAPY
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- Trichodysplasia spinulosa-Associated Polyomavirus (TSV) and Merkel Cell Polyomavirus: Correlation between Humoral and Cellular Immunity Stronger with TSV
- (2012) Arun Kumar et al. PLoS One
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity
- (2012) P. S. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly Conserved Protective Epitopes on Influenza B Viruses
- (2012) C. Dreyfus et al. SCIENCE
- A review of influenza haemagglutinin receptor binding as it relates to pandemic properties
- (2012) Sam Wilks et al. VACCINE
- RNA-based vaccines
- (2012) Jeffrey B. Ulmer et al. VACCINE
- Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection
- (2012) Fu-Shi Quan et al. VIROLOGY
- Anti-viral CD8 T cells and the cytokines that they love
- (2012) Maureen A. Cox et al. VIROLOGY
- The rationale for quadrivalent influenza vaccines
- (2012) Christopher S. Ambrose et al. Human Vaccines & Immunotherapeutics
- DNA Vaccination Elicits Protective Immune Responses against Pandemic and Classic Swine Influenza Viruses in Pigs
- (2011) J. Patrick Gorres et al. Clinical and Vaccine Immunology
- Viral vectors as vaccine platforms: deployment in sight
- (2011) Christine S Rollier et al. CURRENT OPINION IN IMMUNOLOGY
- Live Attenuated Influenza Vaccine (FluMist®; Fluenz™)
- (2011) Natalie J. Carter et al. DRUGS
- The future of cell culture-based influenza vaccine production
- (2011) Michael L Perdue et al. Expert Review of Vaccines
- ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway
- (2011) Nicholas S Wilson et al. IMMUNOLOGY AND CELL BIOLOGY
- DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
- (2011) Julie E Ledgerwood et al. LANCET INFECTIOUS DISEASES
- Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA
- (2011) Federico Perche et al. Nanomedicine-Nanotechnology Biology and Medicine
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
- (2011) Scott G. Hansen et al. NATURE
- Influenza A viruses: new research developments
- (2011) Rafael A. Medina et al. NATURE REVIEWS MICROBIOLOGY
- Polyvalent DNA Vaccines Expressing HA Antigens of H5N1 Influenza Viruses with an Optimized Leader Sequence Elicit Cross-Protective Antibody Responses
- (2011) Shixia Wang et al. PLoS One
- Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin
- (2011) J. R. R. Whittle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
- (2011) D. Corti et al. SCIENCE
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
- (2011) S. Khurana et al. Science Translational Medicine
- A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets
- (2011) Brendan M. Giles et al. VACCINE
- Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50–64 years of age☆
- (2011) R. Baxter et al. VACCINE
- A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection
- (2010) Saori Sakabe et al. ANTIVIRAL RESEARCH
- Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
- (2010) S. Kreiter et al. CANCER RESEARCH
- Virus-like particles in vaccine development
- (2010) António Roldão et al. Expert Review of Vaccines
- Original Article: Highly conserved cross-reactive CD4+ T-cell HA-epitopes of seasonal and the 2009 pandemic influenza viruses
- (2010) Venkata R. S. K. Duvvuri et al. Influenza and Other Respiratory Viruses
- Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
- (2010) Steven J. Gamblin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
- (2010) Davide Corti et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunity to Pre-1950 H1N1 Influenza Viruses Confers Cross-Protection against the Pandemic Swine-Origin 2009 A (H1N1) Influenza Virus
- (2010) I. Skountzou et al. JOURNAL OF IMMUNOLOGY
- Research and development of universal influenza vaccines
- (2010) Lanying Du et al. MICROBES AND INFECTION
- A Universal Influenza A Vaccine Based on Adenovirus Expressing Matrix-2 Ectodomain and Nucleoprotein Protects Mice From Lethal Challenge
- (2010) Dongming Zhou et al. MOLECULAR THERAPY
- Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
- (2010) Dan H Barouch et al. NATURE MEDICINE
- Influenza Vaccines for the Future
- (2010) Linda C. Lambert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses
- (2010) Graeme E. Price et al. PLoS One
- Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
- (2010) G. Bommakanti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Composition and Functions of the Influenza Fusion Peptide
- (2010) Karen Cross et al. PROTEIN AND PEPTIDE LETTERS
- Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
- (2010) S. Khurana et al. Science Translational Medicine
- Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines
- (2010) Kanyarat Thueng-in et al. VACCINE
- Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin
- (2010) Larry R. Smith et al. VACCINE
- TLR-based immune adjuvants
- (2010) Folkert Steinhagen et al. VACCINE
- Influenza A viruses: why focusing on M2e-based universal vaccines
- (2010) Seyyed Mahmoud Ebrahimi et al. VIRUS GENES
- Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
- (2010) J. Steel et al. mBio
- Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus
- (2010) Rafael A. Medina et al. Nature Communications
- Glycosylation Focuses Sequence Variation in the Influenza A Virus H1 Hemagglutinin Globular Domain
- (2010) Suman R. Das et al. PLoS Pathogens
- Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins
- (2010) Taia T. Wang et al. PLoS Pathogens
- Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
- (2009) Michael Schotsaert et al. Expert Review of Vaccines
- Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4+ T-cell responses to internal proteins, hemagglutinins, and neuraminidases
- (2009) Jenny Aurielle B. Babon et al. HUMAN IMMUNOLOGY
- Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1)
- (2009) Shi-gui Yang et al. VACCINE
- Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses
- (2009) J.H.C.M. Kreijtz et al. VACCINE
- Current challenges in implementing cell-derived influenza vaccines: Implications for production and regulation, July 2007, NIBSC, Potters Bar, UK
- (2009) Philip D. Minor et al. VACCINE
- M2e-based universal influenza A vaccine
- (2009) Walter Fiers et al. VACCINE
- Monoclonal antibody-based therapies for microbial diseases
- (2009) Carolyn Saylor et al. VACCINE
- Influenza vaccines based on virus-like particles
- (2009) Sang-Moo Kang et al. VIRUS RESEARCH
- Kinetics of Recombinant Adenovirus Type 5, Vaccinia Virus, Modified Vaccinia Ankara Virus, and DNA Antigen Expression In Vivo and the Induction of Memory T-Lymphocyte Responses
- (2008) R. Geiben-Lynn et al. Clinical and Vaccine Immunology
- Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals
- (2008) Laurel Yong-Hwa Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
- (2008) Rafick-Pierre Sekaly JOURNAL OF EXPERIMENTAL MEDICINE
- Cross-Recognition of Avian H5N1 Influenza Virus by Human Cytotoxic T-Lymphocyte Populations Directed to Human Influenza A Virus
- (2008) J. H. C. M. Kreijtz et al. JOURNAL OF VIROLOGY
- Incorporation of Membrane-Anchored Flagellin into Influenza Virus-Like Particles Enhances the Breadth of Immune Responses
- (2008) B.-Z. Wang et al. JOURNAL OF VIROLOGY
- Effective induction of high-titer antibodies by viral vector vaccines
- (2008) Simon J Draper et al. NATURE MEDICINE
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
- Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
- (2008) Mark Throsby et al. PLoS One
- Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design
- (2007) Juliana Bessa et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started